98%
921
2 minutes
20
Purpose: To present a case of struma ovarii with a typical features and synchronous primary thyroid carcinoma and review the available literature to guide diagnosis and management of these tumors.
Methods: We present a case from our hospital of a 55-year-old woman who had an adnexal mass with features concerning for papillary thyroid carcinoma and was ultimately determined to be struma ovarii with atypical features. Subsequent thyroid imaging and biopsy revealed a primary cervical thyroid carcinoma. We performed a PubMed search of published English language articles using the search terms "malignant struma ovarii," "metastatic struma ovarii," "struma ovarii with malignant transformation," "struma ovarii papillary thyroid carcinoma," "struma ovarii follicular thyroid carcinoma," and "struma ovarii with concurrent primary thyroid carcinoma."
Results: Literature review included 104 studies with a total of 195 patient cases. The average age at presentation was 44.9 years. 25.1% of patients had metastatic disease at presentation, and 6.2% had synchronous primary carcinomas; all of which were located in the thyroid.
Conclusions: Thyroid carcinoma arising in struma ovarii or mature cystic teratoma should prompt clinical evaluation and imaging of the thyroid given the possibility of synchronous primaries, metastases, and recurrence.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00404-019-05329-z | DOI Listing |
Cureus
August 2025
Faculty of Medicine, University of Costa Rica, San José, CRI.
Struma ovarii (SO) is a rare form of ovarian teratoma predominantly composed of thyroid tissue. While most cases follow a benign course, some may exhibit malignant transformation or extra-ovarian spread. We present the case of a 43-year-old woman with a history of SO previously treated with right oophorectomy and systemic chemotherapy, along with a separate diagnosis of papillary thyroid carcinoma managed with total thyroidectomy and radioactive iodine ablation.
View Article and Find Full Text PDFMedicine (Baltimore)
August 2025
Department of Obstetrics and Gynecology, Faculty of Medicine, Saga University, Saga, Japan.
Rationale: Struma ovarii is a rare form of mature cystic teratoma, with malignant transformation reported in approximately 5% to 10% of cases. Transformation into follicular thyroid carcinoma (FTC) is extremely uncommon; as a result, no standardized guidelines exist for treatment or prognosis for such cases.
Patient Concerns: A 54-year-old woman with cholelithiasis presented with upper abdominal discomfort.
Life (Basel)
August 2025
Obstetrics and Gynecology Department, Hospital Materno-Infantil, Hospital Regional Universitario Málaga, Avenida Arroyo de los Ángeles S/N, 29011 Málaga, Spain.
Adnexal tumors during pregnancy are rare, with a prevalence ranging from 0.05% to 3%, and in most cases, they are benign. Struma ovarii, a monodermal teratoma, consists of over 50% thyroid tissue and accounts for 2.
View Article and Find Full Text PDFIndian J Nucl Med
June 2025
Department of Nuclear Medicine, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.
Struma ovarii (SO) is a rare ovarian teratoma with predominant thyroid tissue. Malignant SO (MSO) occurs in 5%-10% of cases, with papillary and follicular thyroid carcinomas being the most common malignant types. The disease is typically diagnosed in women aged 40-60 years, and management protocols are not well defined due to its rarity.
View Article and Find Full Text PDFBr J Radiol
July 2025
Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, 00168, Italy.
Gynaecological tumours present a broad spectrum of histological subtypes due to the diverse anatomical and tissue origin of the reproductive organs. Rare tumours affect less than 6 per 100,000 individuals annually, posing significant challenges in diagnosis and management due to limited clinical awareness. Indeed, treatment protocols rely on options developed for more common histotypes, which may have limited efficacy on these rare tumours.
View Article and Find Full Text PDF